Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Bnai Zion Medical Center.
Recruitment status was  Recruiting
Information provided by:
Bnai Zion Medical Center
ClinicalTrials.gov Identifier:
First received: December 6, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

Condition Intervention Phase
Behavioral: hypnosis
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

Resource links provided by NLM:

Further study details as provided by Bnai Zion Medical Center:

Primary Outcome Measures:
  • salivaa volume
  • quality of life related to salivation

Estimated Enrollment: 10
Study Start Date: November 2006
Estimated Study Completion Date: December 2006
Detailed Description:
10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • radiotherapy for head and neck cancer
  • xerostomia

Exclusion Criteria:

  • psychiatric illness (present or past)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00408759

Contact: elad schiff 972482654767 eschiff@email.arizona.edu
Contact: gorge mogilner 97248359359 eschiff@bezeqint.net

bnai zion MC Recruiting
Haifa, Israel
Contact: elad schiff    97248359767    eschiff@email.arizona.edu   
Sub-Investigator: Gorge Mogilner         
Sub-Investigator: Noam Yarom         
Sub-Investigator: Ilana Dowek         
Sponsors and Collaborators
Bnai Zion Medical Center
Principal Investigator: Elad Schiff Bnai Zion MC
  More Information

ClinicalTrials.gov Identifier: NCT00408759     History of Changes
Other Study ID Numbers: eschiff 
Study First Received: December 6, 2006
Last Updated: December 6, 2006
Health Authority: Israel: Ministry of Health

Keywords provided by Bnai Zion Medical Center:
dry mouth
head and neck cancer

Additional relevant MeSH terms:
Mouth Diseases
Salivary Gland Diseases
Stomatognathic Diseases

ClinicalTrials.gov processed this record on May 23, 2016